Goodwill Pharma Expands Production, Warehouse Capacity

Hungary's Goodwill Pharma Plc. has expanded its warehouse capacity, built a research and development and innovation laboratory, a new head office and a pharmaceutical manufacturing plant in Szeged, Hungary, the almost HUF 5 billion investment was handed over on Thursday.

Ferenc Jójárt, CEO of the Szeged-based company, said at the ceremony that Goodwill Pharma is proof of how a rural town in Hungary can become a multinational pharmaceutical company.

Between June 2022 and the end of November last year, three sites were developed under the Hungarian Multi Program, with HUF 1.767 billion in conditional non-reimbursable EU and national funding.

The company has built a logistics center for storing 4-5,000 pallets of medicines. It has built a production plant that meets pharmaceutical industry standards, and the first machines have already arrived, so that the first medicines produced in Szeged could be ready by the end of the year or early next year.

To expand its research and development activities, the company has built a new pharmaceutical laboratory and a new office building in the centre of Szeged, the CEO said, giving details of the developments. The company is planning to enter the standard market of the Budapest Stock Exchange (BSE) within a month, to carry out a further private capital increase and, if the market situation allows, to launch a public offering in the second half of the year, he said.